Phase 1 Motor Neuron Disease Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Completed
Phase 1
An open-label, phase 1b study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of PMX205 in patients with amyotrophic lateral sclerosis
Amyotrophic Lateral SclerosisMotor Neuron DiseaseParkinson's Disease
Alsonex Pty Ltd8 enrolled1 locationACTRN12622000927729
Completed
Phase 1
A randomised, double-blind, placebo-controlled, phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple ascending doses of PMX205 in healthy volunteers.
Motor Neuron DiseaseParkinson's Disease
Alsonex Pty Ltd54 enrolled1 locationACTRN12619001639112
Completed
Phase 1
A randomised, controlled phase 1 study to investigate the safety and efficacy of orally administered squalamine in subjects with Motor Neuron Disease
Motor Neuron Disease
Wesley Medical Research30 enrolled1 locationACTRN12619000375156
Terminated
Phase 1
A trial to evaluate the effect of FLX-787 ODT on Motor Neuron Disease.
Spasticity & cramps in patients with Motor Neuron Disease
Flex Pharma, Inc50 enrolled3 locationsACTRN12616001060437